NasdaqGM - Delayed Quote USD

Apogee Therapeutics, Inc. (APGE)

53.22

+0.30

(+0.57%)

At close: May 10 at 4:00 PM EDT

61.60

+8.38

(+15.75%)

After hours: May 10 at 4:47 PM EDT

Key Events

Loading Chart for APGE

9/21 12:03 PM

DELL

Previous Close 52.92
Open 56.10
Bid 52.98 x 300
Ask 53.38 x 100
Day's Range 51.30 - 56.10
52 Week Range 14.19 - 72.29
Volume 211,163
Avg. Volume 689,750
Market Cap (intraday) 3.11B
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 85.80

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

www.apogeetherapeutics.com

91

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APGE

90.48%

S&P 500

9.49%

1-Year Return

APGE

--

S&P 500

15.92%

3-Year Return

APGE

--

S&P 500

15.92%

5-Year Return

APGE

--

S&P 500

15.92%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Apogee Therapeutics, Inc.

53.22

+0.57%

Mkt Cap 3.11B

Industry Biotechnology

Spyre Therapeutics, Inc.

36.93

+4.94%

Mkt Cap 1.488B

Industry Biotechnology

Krystal Biotech, Inc.

154.76

-2.50%

Mkt Cap 4.42B

Industry Biotechnology

MoonLake Immunotherapeutics

40.92

-2.50%

Mkt Cap 2.573B

Industry Biotechnology

AnaptysBio, Inc.

23.41

-10.75%

Mkt Cap 639.528M

Industry Biotechnology

Mineralys Therapeutics, Inc.

13.52

-5.26%

Mkt Cap 671.014M

Industry Biotechnology

44.52

-1.33%

Mkt Cap 2.613B

Industry Biotechnology

Viridian Therapeutics, Inc.

13.90

-0.07%

Mkt Cap 887.133M

Industry Biotechnology

IDEAYA Biosciences, Inc.

41.17

+1.30%

Mkt Cap 3.116B

Industry Biotechnology

Immunovant, Inc.

29.39

-1.04%

Mkt Cap 4.27B

Industry Biotechnology

Vera Therapeutics, Inc.

41.32

-2.39%

Mkt Cap 2.25B

Industry Biotechnology

Valuation Measures

As of 5/10/2024

Market Cap

3.00B
Enterprise Value

2.61B
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

5.96
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-21.00%
Return on Equity (ttm)

-32.18%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-83.98M
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

395.46M
Total Debt/Equity (mrq)

0.54%
Levered Free Cash Flow (ttm)

-45.5M

APGE does not have Company Insights

JANX Janux Therapeutics, Inc.

48.92

-5.81%

ACLX Arcellx, Inc.

49.74

-5.67%

NMRA Neumora Therapeutics, Inc.

9.19

-5.94%

GPCR Structure Therapeutics Inc.

35.82

-7.32%

SLRN Acelyrin, Inc.

4.6800

-4.10%

VERA Vera Therapeutics, Inc.

41.32

-2.39%

NUVL Nuvalent, Inc.

65.48

-3.02%

CRNX Crinetics Pharmaceuticals, Inc.

48.00

-2.87%

ALPN Alpine Immune Sciences, Inc.

64.94

+0.19%

SYRE Spyre Therapeutics, Inc.

36.93

+4.94%

AVTE Aerovate Therapeutics, Inc.

19.83

-8.02%

SGMT Sagimet Biosciences Inc.

4.4400

-2.84%

KROS Keros Therapeutics, Inc.

54.27

-5.78%

MLYS Mineralys Therapeutics, Inc.

13.52

-5.26%

ACRV Acrivon Therapeutics, Inc.

8.77

+7.74%

EWTX Edgewise Therapeutics, Inc.

18.33

-8.35%